The role of MALAT1 in HCC cell growth was also tested using in vivo experiments, in which the authors injected HepG2 cells transfected with sh-MALAT1 into nude mice; the tumor volume and size in the shRNA knockdown group were smaller than that of the negative control group. Here, MALAT1 is linked to hepatocellular carcinoma.